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Introduction {#cns12400-sec-0005}
============

Stroke is one of the leading causes of death in China and has a significant impact on healthcare expenditures and Chinese economy [1](#cns12400-bib-0001){ref-type="ref"}. There are more patients suffering from intracranial atherosclerotic diseases in China compared with Western countries [2](#cns12400-bib-0002){ref-type="ref"}, [3](#cns12400-bib-0003){ref-type="ref"}. Finding from a recent multicenter study of the prevalence and outcomes of intracranial large artery atherosclerosis among patients with stroke and transient ischemic attack in China (the Chinese Intracranial Atherosclerosis (CICAS) study) showed that the prevalence of intracranial stenosis was up to 46.6% [4](#cns12400-bib-0004){ref-type="ref"}.

Hypertension is an important predictor for stroke outcome; data from CNSR prompted that admission systolic blood pressure was associated with poor outcomes at 3 and 12 months in intracerebral hemorrhage patients [5](#cns12400-bib-0005){ref-type="ref"}. However, the relationship between blood pressure and stroke prognosis was still controversial [6](#cns12400-bib-0006){ref-type="ref"}, [7](#cns12400-bib-0007){ref-type="ref"}. The effect of blood pressure on the prognosis varies depending on the different stroke subtypes [8](#cns12400-bib-0008){ref-type="ref"}. To date, a few studies have investigated the relationship between the blood pressure and prognosis of symptomatic intracranial artery stenosis. Evidence from WASID study indicates that higher blood pressure was associated with greater risk of ischemic stroke and stroke in the territory of the stenotic vessel [9](#cns12400-bib-0009){ref-type="ref"}. Although select bias would not be avoided in a drug clinical trial. Another small sample study shows that patients with higher blood pressure on admission were associated with an increased risk of death or disability in those patients [6](#cns12400-bib-0006){ref-type="ref"}. Therefore, antihypertensive therapies should have positive blood pressure‐independent effects on stroke risk [10](#cns12400-bib-0010){ref-type="ref"}. As blood pressure could be affected by multiple factors, this conclusion is not generalizable. In addition, fewer researches were carried out to study the relationship between blood pressure and stroke functional outcome in patients with different degree of stenosis.

According to JNC 7 [11](#cns12400-bib-0011){ref-type="ref"}, patients were classified into four subgroups by level of blood pressure. The aim of our study was to analyze the relationship between blood pressure and stroke prognosis in patients with various severity of stenosis. A discussion was presented on how blood pressure affects the prognosis of patients with symptomatic intracranial artery stenosis or occlusion.

Materials and Methods {#cns12400-sec-0006}
=====================

Patient Population and Study Design {#cns12400-sec-0007}
-----------------------------------

The CICAS study is a prospective and hospital‐based multicenter study at 22 sites in China. In total, 2864 patients were enrolled in CICAS study, of which 307 had no blood pressure information and 141 had extracranial lesions only, so that they were excluded from the current study. Details of the study design have been published elsewhere [4](#cns12400-bib-0004){ref-type="ref"}. All patients underwent three‐dimensional time‐of‐flight MRA. Extracranial carotid vessels were examined by duplex color Doppler ultrasound or contrast‐enhanced MRA. According to the severity of stenosis, patients were categorized into four groups: \<50% or no stenosis, 50% to 69% stenosis, 70% to 99% stenosis, and occlusion. In accordance with the JNC 7 classification by level of blood pressure, patients was classified into prehypertension (ranging from 120 to 139 mmHg systolic and/or 80 to 89 mmHg diastolic), normal (\<120/80 mmHg), stage I hypertension (ranging from 140 to 159 mmHg systolic and/or 90 to 99 mmHg diastolic), and stage II hypertension (≥160 mmHg systolic and/or ≥100 mmHg diastolic) [11](#cns12400-bib-0011){ref-type="ref"}. During hospitalization, professional nurses made two or more measurements at different time of morning, noon, or afternoon every day. If the patients could not sit, the BP would be measured in the decubitus position. The diagnosis was determined by trained physicians according to the overall level of BP in hospital and past history.

Follow‐up and Endpoints {#cns12400-sec-0008}
-----------------------

Patients were contacted via telephone by trained research personnel from Beijing Tiantan Hospital and Hong Kong Prince of Wales Hospital using standard scripts at discharge and at 12 months after stroke onset. Each case fatality was either confirmed on a death certificate from the local citizen registry or from the attended hospital. Endpoints were disability and any cause of death. The modified Rankin Scale (mRS) scores of 3 to 5 were considered as disabled.

Statistical Analyses {#cns12400-sec-0009}
--------------------

All analyses were carried out with SAS software version 9.1.3 (SAS Institute, Cary, NC, USA). Continuous variables were summarized as median (interquartile range \[IQR\]) or (mean ± SD). Categorical variables such as male sex, vascular risk factors, and classification of blood pressure were presented as percentages. Independent samples of *t*‐test or Wilcoxon\'s test were used for comparison of continuous variables, and chi‐squared test or Fisher\'s exact test was used for comparison of categorical variables. Odds ratios (ORs) and their 95% confidence intervals (CI) for the degree of ICAS (intracranial atherosclerosis) associated with various blood pressure subgroups were calculated using logistic regression analysis. All tests were 2‐sided, with a significance level fixed at 5%.

Results {#cns12400-sec-0010}
=======

Baseline Characteristics {#cns12400-sec-0011}
------------------------

A cohort of 2426 consecutive patients was analyzed in the study. Of total, 1645(67.8%)patients were male. The mean age on admission for index stroke was 61.6 (±11.3) years. The percentage of diabetes mellitus, hyperlipidemia, current smoker, heavy alcohol use, hyperhomocysteinemia, history of previous stroke/TIA, Heart disease, body Mass Index, NIH Stroke Scale at admission, blood creatinine, statins, antiplatelet therapy, blood pressure‐lowering therapy, multiple ICAS, type of vascular lesion, distribution of ICAS, and pattern of infarct were significantly different among subgroups of different hypertension stages by JNC 7, while others had nonsignificant difference. The clinical features of the participants have been summarized in Table [1](#cns12400-tbl-0001){ref-type="table"}.

###### 

Baseline characteristics of 2426 patients by the classification of JNC 7 hypertension stage

  Characteristics                                                        Total            Normal           Prehypertension   Hypertension stage I   Hypertension stage II   *P* value
  ---------------------------------------------------------------------- ---------------- ---------------- ----------------- ---------------------- ----------------------- -----------
  Male sex                                                               1645             333 (71.9)       72 (75.0)         276 (67.0)             964 (66.3)              0.0550
  Age[a](#cns12400-note-0003){ref-type="fn"}, mean, (SD), year           61.6 ± 11.3      58.8 ± 12.5      58.8 ± 12.8       62.9 ± 10.3            62.3 ± 10.9             \<0.0001
  Diabetes mellitus                                                      862              115 (24.8)       27 (28.1)         144 (35.0)             576 (39.6)              \<0.0001
  Hyperlipidemia                                                         1862             328 (70.8)       75 (78.1)         305 (74.0)             1154 (79.3)             0.0010
  Family history of stroke                                               254              39 (8.4)         12 (12.5)         38 (9.2)               165 (11.3)              0.2261
  Current smoker                                                         898              198 (42.8)       48 (50.0)         147 (35.7)             505 (34.7)              0.0007
  Heavy drinker                                                          124              26 (5.6)         10 (10.4)         12 (2.9)               76 (5.2)                0.0189
  Hyperhomocysteinemia                                                   680              98 (21.2)        40 (41.7)         109 (26.5)             433 (29.8)              \<0.0001
  History of previous stroke/TIA                                         1703             261 (56.4)       59 (61.5)         290 (70.4)             1093 (75.1)             \<0.0001
  History of hemorrhage stroke                                           45               9 (1.9)          1 (1.0)           9 (2.2)                26 (1.8)                0.8845
  Heart disease                                                          210              23 (5.0)         9 (9.4)           38 (9.2)               140 (9.6)               0.0193
  Peripheral vascular disease                                            20               2 (0.4)          3 (3.1)           3 (0.7)                12 (0.8)                0.0678
  Body mass index[a](#cns12400-note-0003){ref-type="fn"}                 24.6 ± 3.2       24.0 ± 3.3       24.6 ± 3.0        24.5 ± 3.0             24.8 ± 3.2              \<0.0001
  NIH Stroke Scale at admission[b](#cns12400-note-0004){ref-type="fn"}   4.0 (1.0--7.0)   3.0 (1.0--6.0)   3.0 (1.0--7.0)    4.0 (2.0--7.0)         4.0 (2.0--7.0)          0.0173
  Blood creatinine[a](#cns12400-note-0003){ref-type="fn"}                81.3 ± 37.1      76.0 ± 17.5      75.5 ± 17.1       81.1 ± 37.7            83.4 ± 33.6             0.0002
  Antiplatelet therapy                                                   2274             424 (91.6)       87 (90.6)         371 (90.1)             1392 (95.7)             \<0.0001
  Statins                                                                1867             328 (70.8)       76 (79.2)         310 (75.2)             1153 (79.2)             0.0018
  Blood pressure‐lowering therapy                                        1275             22 (4.8)         22 (22.9)         216 (52.4)             1015 (69.8)             \<0.0001
  Type of vascular lesion                                                                                                                                                   
  None                                                                   1230             268 (57.9)       44 (45.8)         213 (51.7)             705 (48.5)              0.0262
  Intracranial only                                                      949              155 (33.5)       39 (40.6)         157 (38.1)             598 (41.1)              
  Intra‐ and extracranial                                                247              40 (8.6)         13 (13.5)         42 (10.2)              152 (10.5)              
  Multiple ICAS                                                          519              63 (13.6)        20 (10.8)         70 (17.0)              366 (25.2)              \<0.0001
  Distribution of ICAS                                                                                                                                                      
  None                                                                   1230             268 (57.9)       44 (45.8)         213 (51.7)             705 (48.5)              \<0.0001
  Anterior                                                               596              124 (26.8)       38 (39.6)         96 (23.3)              338 (23.2)              
  Posterior                                                              304              39 (8.4)         4 (4.2)           67 (16.3)              194 (13.3)              
  Anterior and posterior                                                 296              32 (6.9)         10 (10.4)         36 (8.7)               218 (15.0)              
  Severity of ICAS                                                                                                                                                          
  None or \<50%                                                          1230             268 (57.9)       44 (45.8)         213 (51.7)             705 (48.5)              0.0056
  50--69%                                                                304              41 (8.9)         11 (11.5)         53 (12.9)              199 (13.7)              
  70--99%                                                                221              29 (6.3)         13 (13.5)         30 (7.3)               149 (10.2)              
  100%                                                                   671              125 (27.0)       28 (29.2)         116 (28.2)             402 (27.6)              
  Multiple infarctions                                                   235              45 (13.7)        10 (13.9)         37 (12.0)              143 (12.8)              0.9224
  Pattern of infarct                                                                                                                                                        
  No infarct                                                             537              124 (27.4)       20 (21.7)         96 (23.8)              297 (21.0)              \<0.0001
  Cortical                                                               93               20 (4.4)         5 (5.4)           19 (4.7)               49 (3.5)                
  Subcortical                                                            945              158 (35.0)       39 (42.4)         164 (40.6)             584 (41.3)              
  Mixed cortical and subcortical                                         331              91 (20.1)        16 (17.4)         50 (12.4)              174 (12.3)              
  Infratentorial                                                         418              52 (11.5)        12 (13.04)        71 (17.6)              283 (20.0)              
  *Supra*‐ and infratentorial                                            37               7 (1.6)          0 (0)             4 (1.0)                26 (1.8)                
  White matter changes                                                   997              117 (25.3)       27 (28.1)         170 (41.3)             683 (47.0)              \<0.0001
  Complete circle of Willis                                              117              30 (6.5)         5 (5.2)           17 (4.1)               65 (4.4)                0.3036
  Border zone                                                            206              47 (10.2)        16 (16.7)         29 (7.0)               114 (7.8)               0.0080

ICAS indicates intracranial atherosclerosis.

Continuous variable with normal distribution was expressed as mean ± SD; other values are expressed as n (%).

NIH Stroke Scale with abnormal distribution was expressed as medians with IQR in parentheses.
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Blood pressure and poor outcome {#cns12400-sec-0012}
-------------------------------

The rate of poor outcome at discharge was found to be increased with higher category of blood pressures. Among patients with stenosis of \<50%, the rate of poor outcome at discharge was 13.06%, 14.63%, 34.48%, and 40.80% (*P* \< 0.0001) in each blood pressure subgroup (from normal, to prehypertension, to hypertension stage I, and to hypertension stage II). Among patients with 50% to 69% stenosis, the rates were 25.0%, 27.3%, 30.8%, and 43.0%, respectively (*P* = 0.4508). In patients with 70% to 99% stenosis, the rate of poor outcome at discharge was 19.3%, 23.5%, 26.7%, and 39.7% (*P* = 0.0010). Among patients with occlusion the rate was 17.6%, 22.1%, 29.5%, and 49.8% (*P* \< 0.0001). The same trend was observed at 12‐month poor outcome. In patients with stenosis \<50%, the rate of poor outcome at discharge were 6.6%, 7.5%, 17.8%, and 28.2% (*P* \< 0.0001). Among patients with 50% to 69% stenosis the rate was 16.6%, 27.2%, 23.0%, and 21.4% (*P* = 0.8592). Among patients with 70% to 99% stenosis, the rate of poor outcome at 12‐month was 12.6%, 15.3%, 28.5%, and 27.9% (*P* = 0.0038). In patients with occlusion the rate was 11.6%, 21.5%, 23.9%, and 35.1% (*P* \< 0.0001). The trend of poor outcome has been shown in Figures [1](#cns12400-fig-0001){ref-type="fig"} and [2](#cns12400-fig-0002){ref-type="fig"}.

![Trends of poor outcome rate at discharge by the degree of stenosis and categories for blood pressure. Number above each block indicates the rate of poor outcome. HP: hypertension; BP: blood pressure.](CNS-21-530-g001){#cns12400-fig-0001}

![Trends of poor outcome rate at 12‐month follow‐up by the degree of stenosis and categories for blood pressure. Number above each block indicates the rate of poor outcome. HP: hypertension; BP: blood pressure.](CNS-21-530-g002){#cns12400-fig-0002}

The degree of ICAS associated with various blood pressure subgroups was calculated using logistic regression analysis adjusted on age, hyperhomocysteinemia, body mass index, NIHSS at admission, distribution of ICAS, border‐zone infarction, degree of stenosis, antiplatelet therapy, statins, blood pressure‐lowering therapy. The adjusted *P* values were all \>0.05. (Table [2](#cns12400-tbl-0002){ref-type="table"})

###### 

Odds ratios and 95% CIs according to categories of JNC 7 for poor outcome at discharge and 12‐month follow‐up

  Classification of BP    Unadjusted           Adjusted[a](#cns12400-note-0006){ref-type="fn"}                                                                                
  ----------------------- -------------------- ------------------------------------------------- -------------------- ------ -------------------- ------ -------------------- ------
  50--69%                                                                                                                                                                     
  Normal                                                                                                                                                                      
  Prehypertension         2.19 (0.45--10.67)   0.57                                              4.62 (0.79--27.23)   0.24   4.45 (0.38--51.98)   0.23   --                   0.94
  Hypertension stage I    1.90 (0.65--5.52)    0.62                                              2.24 (0.55--9.06)    0.82   1.91 (0.26--14.11)   0.53   --                   0.94
  Hypertension stage II   1.66 (0.65--4.19)    0.93                                              3.39 (1.00--11.56)   0.23   1.70 (0.31--9.42)    0.54   --                   0.94
  70--99%                                                                                                                                                                     
  Normal                                                                                                                                                                      
  Prehypertension         0.84 (0.21--3.44)    0.96                                              1.38 (0.28--6.92)    0.99   3.71 (0.33--41.89)   0.29   4.53 (0.53--38.36)   0.17
  Hypertension stage I    0.69 (0.23--2.11)    0.62                                              1.84 (0.52--6.54)    0.45   0.14 (0.01--1.78)    0.13   1.60 (0.24--10.56)   0.63
  Hypertension stage II   0.80 (0.34--1.85)    0.88                                              1.45 (0.51--4.10)    0.87   0.74 (0.11--5.29)    0.77   3.30 (0.60--18.23)   0.17
  100%                                                                                                                                                                        
  Normal                                                                                                                                                                      
  Prehypertension         1.09 (0.48--2.49)    0.96                                              0.69 (0.26--1.87)    0.32   1.36 (0.27--6.94)    0.71   0.86 (0.20--3.71)    0.84
  Hypertension stage I    0.95 (0.57--1.60)    0.41                                              0.99 (0.55--1.76)    0.99   0.89 (0.35--2.22)    0.80   0.95 (0.42--2.17)    0.91
  Hypertension stage II   1.44 (0.96--2.16)    0.06                                              1.38 (0.87--2.17)    0.04   1.84 (0.87--3.89)    0.11   1.36 (0.69--2.69)    0.38

The odds ratios (ORs) and probability values are for comparisons between the lowest blood pressure category and each of the higher blood pressure categories. CI was the abbreviation for confidence intervals.

Adjusted by age, hyperhomocysteinemia, body mass index, NIHSS at admission, distribution of ICAS, border‐zone infarction, degree of stenosis, antiplatelet therapy, statins, blood pressure‐lowering therapy.
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Discussion {#cns12400-sec-0013}
==========

Intracranial large arterial stenosis or occlusion was very common in Chinese ischemic stroke patients [4](#cns12400-bib-0004){ref-type="ref"}. These patients usually had more severe strokes at admission, stayed longer in hospitals and had high risk of recurring strokes, up to 25--30% in 2 years after stroke [12](#cns12400-bib-0012){ref-type="ref"}, [13](#cns12400-bib-0013){ref-type="ref"}, [14](#cns12400-bib-0014){ref-type="ref"}. Only a few large, multicenter randomized trials evaluating stroke‐preventive therapies for this special population have been performed. Hypertension was an important modifiable risk factor. In SAMMPRIS trial, achievement of SBP \<140 mmHg was recommended for patients with severe stenosis (70%--99%) of a major intracranial artery [15](#cns12400-bib-0015){ref-type="ref"}.

Our study provided the data supporting the need to control blood pressure in patients with ICAS. The relationship between blood pressure and functional outcomes in acute ischemic stroke patients with ICAS or occlusion in a hospitalized Chinese population was investigated. The results showed that the rate of poor outcome at discharge and 12‐month follow‐up increased with increase of hypertension stage by JNC 7 criteria in patients with severe stenosis and occlusion. The highest rate of poor outcome was observed among patients with intracranial arterial occlusion and stage II hypertension. However, the hypertension stage was not an independent predictor of poor outcome at discharge or 12‐month follow‐up. In this study, patients with higher hypertension stages were older and likely to have multiple vascular risk factors and higher percentage of multiple intracranial artery lesions, white matter changes, and more cardiac and renal complications. These comorbidities likely contributed to the poor outcome in these patients.

In subanalysis of WASID trial by Turan et al. [9](#cns12400-bib-0009){ref-type="ref"}, increased risk of ischemic stroke and stroke in the territory of the stenotic vessel was found among 567 patients with symptomatic 50% to 99% stenosis of a major intracranial artery and higher BP, even though the data were not grouped together according to the severity of stenosis. In our study, there was no significant correlation between poor outcome and hypertension stage in patients with stenosis of 50--69%. Furthermore, WASID study measured the blood pressure at chronic stage of stroke that included the patients with TIA or nonsevere stroke within 90 days prior to randomization. The relationship of BP and outcome in patients at acute or subacute stage of stroke with ICAS remained uncertain. Zilonghao et al. [6](#cns12400-bib-0006){ref-type="ref"} carried out a similar study of 215 stroke patients within 2 weeks of admission. They observed that higher blood pressure on admission was associated with an increased risk of death or disability among patients with symptomatic ICAS (70%--99%) or occlusion.

According to the pathophysiology, ischemic stroke is due to the abrupt loss of cerebral blood flow to a portion of the brain [8](#cns12400-bib-0008){ref-type="ref"}. Clinic deficits in acute ischemic stroke are caused by both the infracted core and ischemic penumbra. The primary aim of stroke care is to preserve the penumbra, which means optimizing BP and cerebral blood flow. Some studies found a U‐shaped relationship between BP and outcome after ischemic stroke exists [16](#cns12400-bib-0016){ref-type="ref"}, [17](#cns12400-bib-0017){ref-type="ref"}. As the optimal range of BP for the penumbra is small, too much of variation may cause further ischemic damage. The optimal range of BP is unknown and may differ among individuals with different stroke subtypes. This theory had been confirmed by studies from symptomatic carotid artery disease. Rothwell PM et al. [18](#cns12400-bib-0018){ref-type="ref"} found that the risk of stroke increases with blood pressure in the great majority of patients with symptomatic carotid artery disease, but the relationship was less steep than in other patients with TIA or stroke. The relationship was unaffected by unilateral carotid occlusion alone but was inverted among patients with bilateral \>70% carotid stenosis, suggesting that decreasing blood pressure dramatically may not be recommended in these patients.

The current study has several limitations. First, variability and instability in blood pressure had an important role in the progression of organ damage and triggering of vascular events [19](#cns12400-bib-0019){ref-type="ref"}. This study did not take these factors into account. Further research is needed to define the relationship between variability in blood pressure and outcome of patients with intracranial artery stenosis. Second, classification of BP according to JNC 7 does not define very low or high blood pressure. Therefore, our study reflected certain ranges of BP and the outcome. Thirdly, it had been observed that the blood pressure in acute ischemic stroke patients would decline spontaneously within the first week after the onset. In our study, the trained physicians gave the diagnosis at discharge according to the blood pressure of each day during hospitalization and history of hypertension. Further studies should be launched on continuous monitoring of blood pressure after stroke, which may more valuable for prediction.

In conclusion, the rate of poor outcome at discharge and 12‐month follow‐up was increased in patients with elevated hypertension stages defined by JNC 7 and intracranial arterial stenosis of 70--99% or occlusion. The highest rate of poor outcome was observed among patients with occlusion plus stage II hypertension. Patients with higher hypertension stages are older with more vascular risk factors and higher percentage of multiple intracranial arterial lesions, white matter changes, and cardiac and renal complications. Our findings support the need to lower blood pressure in stroke patients with severe ICAS and/or occlusions.
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